摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,2-dihydroxy-3-cyclooctene | 124791-59-9

中文名称
——
中文别名
——
英文名称
1,2-dihydroxy-3-cyclooctene
英文别名
cyclooctene-3,4-diol;(3Z)-Cyclooct-3-ene-1,2-diol
1,2-dihydroxy-3-cyclooctene化学式
CAS
124791-59-9
化学式
C8H14O2
mdl
——
分子量
142.198
InChiKey
AIWBBAVNOGRJMH-HYXAFXHYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    65-69 °C(Press: 6 Torr)
  • 密度:
    1.100±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.9
  • 重原子数:
    10
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.75
  • 拓扑面积:
    40.5
  • 氢给体数:
    2
  • 氢受体数:
    2

文献信息

  • BIO-ORTHOGONAL DRUG ACTIVATION
    申请人:KONINKLIJKE PHILIPS N.V.
    公开号:US20160106859A1
    公开(公告)日:2016-04-21
    The invention relates to a Prodrug activation method, for therapeutics, wherein use is made of abiotic reactive chemical groups that exhibit bio-orthogonal reactivity towards each other. The invention also relates to a Prodrug kit comprising at least one Prodrug and at least one Activator, wherein the Prodrug comprises a Drug and a first Bio-orthogonal Reactive Group (the Trigger), and wherein the Activator comprises a second Bio-orthogonal Reactive Group. The invention also relates to targeted therapeutics used in the above-mentioned method and kit. The invention particularly pertains to antibody-drug conjugates and to bi- and trispecific antibody derivatives.
    该发明涉及一种用于治疗学的原药激活方法,其中使用了表现出彼此生物正交反应性的非生物活性化学基团。该发明还涉及一种包含至少一种原药和至少一种激活剂的试剂盒,其中原药包含药物和第一个生物正交反应基团(触发器),而激活剂包含第二个生物正交反应基团。该发明还涉及在上述方法和试剂盒中使用的靶向治疗剂。该发明特别适用于抗体药物偶联物和双特异性及三特异性抗体生物
  • Concentrated, stable, preferably clear, fabric softening composition
    申请人:Trinh Toan
    公开号:US20060058216A1
    公开(公告)日:2006-03-16
    Principal solvents, especially mono-ol and diol principal solvents, having a ClogP of from about 0.15 to about 0.64, preferably from about 0.25 to about 0.62, and more preferably from about 0.40 to about 0.60, are disclosed that have the ability to make clear aqueous fabric softener compositions containing relatively high concentrations of fabric softener actives having ester linkages in their long, hydrophobic chains. The fabric softener actives are either unsaturated, or have intermediate length chains (˜C 12-14 ) and the said principal solvents are used at levels of less than about 40%. Other solvents may be present. Some of the said principal solvents are novel compounds and/or novel mixtures. Premixes of the fabric softening actives, the principal solvents, and, optionally, other solvents are useful in the preparation of complete formulations by obviating/limiting the need for heating.
    本发明揭示了主要溶剂,特别是具有ClogP约为0.15至约0.64,优选为约0.25至约0.62,更优选为约0.40至约0.60的单醇和双醇主要溶剂,具有制备含有长链疏基中酯键的相对高浓度织物柔顺剂活性成分的清澈性织物柔顺剂组合物的能力。织物柔顺剂活性成分可以是不饱和的,也可以具有中等长度的链(约C12-14),所述主要溶剂的使用平小于约40%。其他溶剂可以存在。其中一些主要溶剂是新化合物和/或新混合物。织物柔顺剂活性成分、主要溶剂和可选的其他溶剂的预混物在制备完整配方时是有用的,因为它们可以避免/限制加热的需要。
  • Concentrated, stable fabric softening composition
    申请人:——
    公开号:US20030153483A1
    公开(公告)日:2003-08-14
    Principal solvents, especially mono-ol and diol principal solvents, having a ClogP of from about 0.15 to about 0.64, preferably from about 0.25 to about 0.62, and more preferably from about 0.40 to about 0.60, are disclosed that have the ability to make clear aqueous fabric softener compositions containing relatively high concentrations of fabric softener actives having ester linkages in their long, hydrophobic chains. The fabric softener actives are either unsaturated, or have intermediate length chains (˜C 12-14 ) and the said principal solvents are used at levels of less than about 40%. Other solvents may be present. Some of the said principal solvents are novel compounds and/or novel mixtures. Premixes of the fabric softening actives, the principal solvents, and, optionally, other solvents are useful in the preparation of complete formulations by obviating/limiting the need for heating.
    本发明涉及主要溶剂,特别是具有从约0.15到约0.64的ClogP值的单醇和二醇主要溶剂,优选从约0.25到约0.62,更优选从约0.40到约0.60,具有使含有长的亲性链中的酯键的织物柔软剂活性成分相对高浓度的清澈性织物柔软剂组合物的能力。织物柔软剂活性成分可以是不饱和的,也可以具有中等长度的链(约C12-14),所述主要溶剂的使用平低于约40%。其他溶剂可能也存在。其中一些主要溶剂是新化合物和/或新混合物。织物柔软剂活性成分、主要溶剂和可选的其他溶剂的预混物可用于制备完整配方,从而避免/限制加热的需要。
  • Concentrated, stable, fabric softening composition
    申请人:THE PROCTER & GAMBLE COMPANY
    公开号:EP1352948A1
    公开(公告)日:2003-10-15
    Principal solvents, especially mono-ol and diol principal solvents, having a ClogP of from about 0.15 to about 0.64, preferably from about 0.25 to about 0.62, and more preferably from about 0.40 to about 0.60, are disclosed that have the ability to make clear aqueous fabric softener compositions containing relatively high concentrations of fabric softener actives having ester linkages in their long, hydrophobic chains. The fabric softener actives are either unsaturated, or have intermediate length chains (∼C12-14) and the said principal solvents are used at levels of less than about 40%. Other solvents may be present. Some of the said principal solvents are novel compounds and/or novel mixtures. Premixes of the fabric softening actives, the principal solvents, and, optionally, other solvents are useful in the preparation of complete formulations by obviating/limiting the need for heating.
    本发明公开了主溶剂,特别是单醇和二醇主溶剂,其 ClogP 值约为 0.15 至 0.64,优选约为 0.25 至 0.62,更优选约为 0.40 至 0.60,这些主溶剂能够制成透明的性织物柔软剂组合物,其中含有相对高浓度的织物柔软剂活性成分,这些活性成分的疏长链中具有酯连接。织物柔软剂活性成分要么是不饱和的,要么具有中间长度的链(∼C12-14),上述主要溶剂的使用量低于约 40%。也可以使用其他溶剂。其中一些主溶剂是新型化合物和/或新型混合物。织物软化活性剂、主溶剂和其他溶剂的预混物可避免/限制加热的需要,从而有助于制备完整的配方。
  • NOVEL POLYMER AND PROCESS FOR PRODUCING THE SAME
    申请人:KURARAY CO., LTD.
    公开号:EP1598384A1
    公开(公告)日:2005-11-23
    A polymer consisting mainly of structural units represented by the general formula (1), wherein the total molar amount of terminal aldehyde groups and acetal groups is 0.6 mol% or smaller based on the total molar amount of the structural units represented by the general formula (1). -[-(-CHR1-)n-CX1R2-CX2R3-]-(1) (In the formula, n is an integer of 2 to 10; X1 and X2 each represents -H, -OH, or a functional group capable of being converted into -OH, provided that at least one of X1 and X2 is hydroxy or a functional group capable of being converted into hydroxy; and R1, R2 and R3 each represents -H or C1-5 alkyl, aryl, aralkyl, or heteroaryl and the two or more R1's may be different).
    一种主要由通式(1)所代表的结构单元组成的聚合物,其中末端醛基和缩醛基的摩尔总量占通式(1)所代表的结构单元摩尔总量的 0.6 摩尔%或更小。-[-(-CHR1-)n-CX1R2-CX2R3-]-(1) (式中,n 为 2-10 的整数;X1 和 X2 各自代表-H、-OH 或可转化为-OH 的官能团,条件是 X1 和 X2 中至少有一个是羟基或可转化为羟基的官能团;R1、R2 和 R3 各自代表-H 或 C1-5 烷基、芳基、芳烷基或杂芳基,两个或多个 R1 可以不同)。
查看更多